Estrogen detoxification meets cancer risk and microplastic exposure
BONUS: Cancer, Estrogen and Detox: What Happens After Your Body Uses Estrogen
The episode connects estrogen metabolism, menopause, lifestyle, environmental exposures, and cancer biology while separating biochemical mechanisms from stronger clinical claims.
- 1Estrogen metabolism involves multiple receptors and pathways, making detoxification more complex than a single supplement or cleanse.
- 2Sulforaphane and NRF2 feature prominently, but the guests acknowledge that laboratory findings and supplement claims do not automatically translate into clinical outcomes.
- 3Hormone health also depends on nutrition, exercise, mitochondrial function, and limiting exposures such as xenoestrogens and microplastics.
Don't miss
David Roberts explains how laboratory testing distinguishes circulating tumor cells from slower-growing cancer stem cells, sharpening the episode’s caution about translating supplement research into treatment claims.
The brief
John Gildea and David Roberts frame estrogen metabolism as a network of receptors and pathways, not a single process that supplements can simply switch on or off.
Sulforaphane becomes the episode’s main molecular example: the guests describe NRF2 as a cellular signaling hub that activates antioxidant and protective enzymes across detoxification pathways.
The discussion treats menopause and hormone replacement as questions of risk and context, linking estrogen’s protective roles with cancer biology, mitochondrial function, and aging.
A breast cancer case study and laboratory work on tumor and cancer stem cells illustrate the gap between promising mechanisms, individualized treatment decisions, and proven clinical benefit.
The conversation widens to xenoestrogens and microplastics, then returns to its practical thesis: nutrition, exercise, and exposure reduction matter alongside supplements and hormones.
Featuring
MicroplasticsListen to the full episode and explore every guest, topic, and moment on PodLume.